Trial Profile

Pivotal phase III trial of eniluracil in combination with fluorouracil and lecovorin in patients with metastatic breast cancer

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 20 Jun 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Eniluracil (Primary) ; Fluorouracil; Folinic acid
Indications Advanced breast cancer
Focus Registrational; Therapeutic Use

Most Recent Events

23 May 2013 The US FDA recommended that Adherex consider other larger clinical trial design alternatives for future development; Adherex is reviewing the feasibility of these and other clinical options.
03 Apr 2013 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com